A

P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID-19

HemaSphere, vol. 6, pp. 899–900

Abstract

Background: Risk factors for severe COVID-19 in myeloproliferative neoplasms (MPN) have been extensively explored. However, no information is available on risk factors to hospitalization at COVID-19 diagnosis. Aims: To provide an evidence-based triage and inform for a timely and antiviral therapy prescription in early phases of viral replication. Methods: The MPN-COVID study is still enrolling consecutive adult MPN patients with COVID-19 infection since February 15, 2020. Among 479 patients (ET n=175, PV n=158, MF n=91, and pre-PMF n=55) with COVID-19 from Feb 2020 to Jun 2021, 248 (52%) were managed at home and 231 (48%) were hospitalized. Results: Univariate analysis Compared to outpatients, those admitted to hospital were more likely to be men (58.9% vs. 45.2%, p=0.003), older than 70 years (61.3% vs. 29.0%, p<.001), with at least one comorbidity (79.7% vs. 55.5%, p<.001) and a history of thrombosis (26.5% vs. 16.6%, p=0.008). Overt myelofibrosis (MF) cases were more frequent in hospital (38.5% vs. 18.1%, p<.001) than PV, ET or pre-PMF. Ruxolitinib was more frequently used in patients who underwent to hospital than managed at home. (25.7% vs. 12.1%, p<.001). In comparison with outpatients, hospitalized cases had a significantly lower median values of hemoglobin (12.1 vs. 13.3 g/dL, p<.001), platelets (250 vs. 390 x109/L, p<.001), absolute lymphocytes (0.8 vs. 1.4 x109/L, p<.001) and higher neutrophil counts (5.1 vs. 4.5 x109/L, p=0.022), leading to a significant increase of neutrophil to lymphocyte ratio (NLR) (6.6 vs. 3.2, p<.001). Compared to lymphocytopenia, the best sensitivity and specificity was found for NLR, whose AUC was 77.28% by ROC analysis. Multivariate analysis By adjusting for sex, comorbidity, fever, systemic symptoms, O2 saturation, previous thrombosis, MPN type, ruxolitinib exposure, and first vs. subsequent waves and vaccination period, three factors emerged as independent predictors of hospitalization: age over 70 years, (OR=3.02, p=0.038), dyspnea (OR=7.23, p<.001) and NLR ≥4, (OR=6.94, p<.001). Interaction model of risk factors In a model fitted to test the interaction terms of the three significant variables, we evaluated the marginal effect of NLR and dyspnea across different age classes (Figure) and found that in younger patients (i.e., from 50 to 70 years) dyspnea was the stronger predictor than increased NLR; conversely, both dyspnea and NLR showed a high and comparable marginal effect in age >80 years. Remarkably, the probability of hospitalization consistently exceeded 90% for any age group when dyspnea and NLR were concomitantly present, and their combination was more prevalent in MF (42%) than in the other phenotypes (24%, 25% and 29% in pre-PMF, PV and ET patients, respectively). In addition to predict hospitalization, dyspnea and NLR≥4 were also associated with severity of COVID-19 illness in terms of respiratory support at hospitalization (OR=2.44, p=0.023). Of note, only age >70 years and NLR higher than 6 were predictors of survival in hospitalized patients (OR=3.24, p=0.007 and OR=5.41, p=0.041, respectively). Image:Summary/Conclusion: For triage purposes of MPN patients tested positive for COVID-19, dyspnea, age and NLR are powerful predictors of hospitalization and identify patients at higher probability of invasive or non-invasive respiratory support and survival, particularly in overt MF. This MPN subgroup at high risk for progression to severe COVID-19 disease should be prioritized for antiviral therapy, even in the ambulatory setting.

Authors 51

  1. T. Barbui corresponding

    FROM – Fondazione per la Ricerca Ospedale di Bergamo ETS

    Affiliation as printed

    FROM Research Foundation, Bergamo

  2. FROM – Fondazione per la Ricerca Ospedale di Bergamo ETS

    Affiliation as printed

    FROM Research Foundation, Bergamo

  3. FROM – Fondazione per la Ricerca Ospedale di Bergamo ETS

    Affiliation as printed

    FROM Research Foundation, Bergamo

  4. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Affiliation as printed

    Hematology division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

  5. University of Wrocław · Wroclaw Medical University

    Affiliation as printed

    Department of Hematology, Blood neoplasms and Bone marrow transplantation, Wroclaw Medical University, Wroclaw, Poland

  6. Azienda Ospedaliera San Gerardo

    Affiliation as printed

    Hematology division and Bone marrow transplant unit, San Gerardo Hospital, ASST Monza, Monza

  7. University of Pavia

    Affiliation as printed

    Department of Molecular medicine, University of Pavia, Pavia

  8. Agostino Gemelli University Polyclinic · Istituti di Ricovero e Cura a Carattere Scientifico

    Affiliation as printed

    Fondazione Policlinico “A. Gemelli” IRCCS, Rome

  9. IRCCS Ospedale San Raffaele

    Affiliation as printed

    IRCCS Ospedale San Raffaele, Milan

  10. Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

    Affiliation as printed

    AOU SS. Antonio e Biagio e C. Arrigo, Alessandria

  11. Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    Affiliation as printed

    ASST Spedali Civili, Brescia, Italy

  12. Hospital Universitario La Paz

    Affiliation as printed

    Hospital Univeristario La Paz, Madrid

  13. Hospital Universitario de Burgos

    Affiliation as printed

    Hospital Universitario de Burgos, Burgos

  14. Vall d'Hebron Hospital Universitari · Vall d'Hebron Institute of Oncology

    Affiliation as printed

    Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus

  15. Hospital Del Mar

    Affiliation as printed

    Hospital del Mar, Barcelona, Spain

  16. IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

    Affiliation as printed

    IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

  17. University of Florence · Azienda Ospedaliero-Universitaria Careggi

    Affiliation as printed

    Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence

  18. Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

    Affiliation as printed

    AOU Città della Salute e della Scienza di Torino, Torino, Italy

  19. Guy's and St Thomas' NHS Foundation Trust

    Affiliation as printed

    Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom

  20. Hospital Universitario Infanta Leonor

    Affiliation as printed

    Hospital Universitario Infanta Leonor, Madrid, Spain

  21. University of Verona

    Affiliation as printed

    Ospedale Policlinico “G.B. Rossi”, Borgo Roma, Verona, Italy

  22. Hospital Clínic de Barcelona

    Affiliation as printed

    Hospital Clinic de Barcelona, Barcelona, Spain

  23. Hôpital Saint-Louis

    Affiliation as printed

    Hospital Saint-Louis, Paris, France

  24. Hospital Clínico San Carlos

    Affiliation as printed

    Hospital Clinico San Carlos, Madrid, Spain

  25. Azienda Ospedaliero Universitaria Maggiore della Carita

    Affiliation as printed

    AOU Maggiore della Carità, Novara, Italy

  26. Hospital Universitario de Móstoles

    Affiliation as printed

    Hospital Universitario de Mostoles, Madrid, Spain

  27. Johannes Wesling Klinikum Minden

    Affiliation as printed

    University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, Germany

  28. Instituto Ramón y Cajal de Investigación Sanitaria · Hospital Universitario Ramón y Cajal

    Affiliation as printed

    Hospital Ramon y Cajal, IRYCIS, Madrid

  29. Hospital General Universitario de Albacete · Complejo Hospitalario Universitario de Albacete

    Affiliation as printed

    Hospital General Universitario de Albacete, Albacete

  30. Hospital Universitario Príncipe de Asturias

    Affiliation as printed

    Hospital Universitario Principe de Asturias, Alcalà de Henares, Madrid, Spain

  31. Ospedale San Bortolo

    Affiliation as printed

    Ospedale San Bortolo, Vicenza, Italy

  32. INCLIVA Health Research Institute · Hospital Clínico Universitario de Valencia

    Affiliation as printed

    Hospital Clinico Universitario, INCLIVA, Valencia

  33. Hospital General Universitario Gregorio Marañón

    Affiliation as printed

    Hospital Gregorio Maranon

  34. Hospital de Sant Joan Despí Moisès Broggi · Institut Català d'Oncologia

    Affiliation as printed

    ICO L’Hospitalet-Hospital Moises Broggi, Sant Joan Despì, Barcelona, Spain

  35. University of Zagreb · University Hospital Dubrava

    Affiliation as printed

    Department of haematology, Clinic of internal medicine, University Hospital Dubrava-School of Medicine University of Zagreb, Zagreb, Croatia

  36. Affiliation as printed

    Hospital Moncloa, Madrid

  37. Hospital Universitari de Girona Doctor Josep Trueta

    Affiliation as printed

    ICO Girona Hospital Josep Trueta, Girona

  38. Hospital Universitari Germans Trias i Pujol

    Affiliation as printed

    ICO Hospital Germans Trias i Pujol, Badalona (Barcelona)

  39. Hospital General Universitario de Elche

    Affiliation as printed

    Hospital General de Elche, Elche (Alicante), Spain

  40. RWTH Aachen University

    Affiliation as printed

    Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany

  41. Affiliation as printed

    Department of Hematology and Internal Diseases, State Hospital, Opole, Poland

  42. University of Milan · University of Wrocław · Wroclaw Medical University · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · Azienda Ospedaliera San Gerardo

    Affiliation as printed

    Department of Hematology, Blood neoplasms and Bone marrow transplantation, Wroclaw Medical University, Wroclaw, Poland

    Hematology division and Bone marrow transplant unit, San Gerardo Hospital, ASST Monza, Monza

    Hematology division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    Università degli Studi di Milano, Milano, Italy

  43. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Affiliation as printed

    Hematology division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

  44. Azienda Ospedaliera San Gerardo

    Affiliation as printed

    Hematology division and Bone marrow transplant unit, San Gerardo Hospital, ASST Monza, Monza

  45. University of Pavia

    Affiliation as printed

    Department of Molecular medicine, University of Pavia, Pavia

  46. Agostino Gemelli University Polyclinic · Istituti di Ricovero e Cura a Carattere Scientifico

    Affiliation as printed

    Fondazione Policlinico “A. Gemelli” IRCCS, Rome

  47. Guy's and St Thomas' NHS Foundation Trust

    Affiliation as printed

    Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom

  48. Hospital Clínic de Barcelona

    Affiliation as printed

    Hospital Clinic de Barcelona, Barcelona, Spain

  49. Hôpital Saint-Louis

    Affiliation as printed

    Hospital Saint-Louis, Paris, France

  50. University of Milan · University of Wrocław · Wroclaw Medical University · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · Azienda Ospedaliera San Gerardo · Ospedale Papa Giovanni XXIII

    Affiliation as printed

    Department of Hematology, Blood neoplasms and Bone marrow transplantation, Wroclaw Medical University, Wroclaw, Poland

    Hematology division and Bone marrow transplant unit, San Gerardo Hospital, ASST Monza, Monza

    Hematology division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    ASST Papa Giovanni XXIII, Bergamo

    Università degli Studi di Milano, Milano, Italy

  51. University of Florence · Azienda Ospedaliero-Universitaria Careggi

    Affiliation as printed

    Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-06).

References 0